Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): Relationship between serum FSH and efficacy

Human Reproduction Update

Volumn 2, Issue 2, 1996, Pages 153-161

  Mannaerts, Bernadette M J L ^a   Rombout, Ferdy ^a   Out, Henk J ^a   Bennink, Herjan Coelingh ^a  

^a NV ORGANON   (Netherlands)

Author keywords

FSH; Pharmacodynamics; Pharmacokinetics; Puregon; rFSH

Indexed keywords

LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; ESTROGEN SYNTHESIS; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

CLINICAL TRIALS; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HALF-LIFE; HUMANS; LYNESTRENOL; MALE; MESTRANOL; RECOMBINANT PROTEINS; SEX FACTORS;

EID: 0029999758     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/2.2.153     Document Type: Review

References (23)

1. De Leeuw, R., Mulders, J., Voortman, G., Rombout, F., Damm, J. and Kloosterboer, L. (1996) Structure-function relationship of recombinant follicle stimulating hormone (Puregan®). Mol. Hum. Reprod., 2, in press.
2. Devroey, P., Van Steirteghem, A., Mannaerts, B. and Coelingh Bennink, H. (1992a) Successful in-vitro fertilization and embryo transfer after treatment with recombinant human FSH. Lancet, 339, 1170-1171.
3. Devroey, P., Van Steirteghem, A., Mannaerts, B. and Coelingh Bennink, H. (1992b) First singleton term birth after ovarian super-ovulation with recombinant human follicle stimulating hormone (Org 32489). Lancet, 340, 1108.
4. Devroey, P., Mannaerts, B., Smitz, J., Coelingh Bennink, H. and Van Steirteghem, A. (1993) First established pregnancy and birth after ovarian stimulation with recombinant human FSH (Org 32489). Hum. Reprod., 8, 863-865.
5. Devroey, P., Mannaerts, B., Smitz, J., Coelingh Bennink, H. and Van Steirteghem, A. (1994) Clinical outcome of a pilot efficacy study on recombinant human FSH (Org 32489) combined with various GnRH agonist regimens. Hum. Reprod., 9, 1064-1069.
6. Germond, M., Dessole, S., Senn, A., Loumaye, E., Howles, C. and Beltrami, V. (1992) Successful in-vitro fertilization and embryo transfer after treatment with recombinant human FSH. Lancet, 339, 1170.
7. Le Cotonnec, J.-Y., Porchet, H.C., Beltrami, V., Khan, A., Toon, S. and Rowland, M. (1994a) Clinical pharmacology of recombinant human follicle stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil. Steril., 61, 669-678.
8. Le Cotonnec, J.-Y., Porchet, H.C., Beltrami, V., Khan, A., Toon, S. and Rowland, M. (1994b) Clinical pharmacology of recombinant human follicle stimulating hormone. II. Single doses and steady state pharmacokinetics. Fertil Steril., 61, 679-686.
9. Loumaye, E., Campbell, R. and Salat-Baroux, J. (1995) Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum. Reprod. Update, 1, 188-199.
10. Mannaerts, B.M.J.L., Kloosterboer, H.J. and Schuurs, A.H.W.M. (1987) Applications of in vitro bioassays for gonadotrophins. In Rolland, R., Heineman, M.J., Naaktgeboren, N., Schoemaker, J., Vemer, H. and Willemsen, W.N.P. (eds), Neuro-endocrinology of Reproduction. Elsevier, Amsterdam, The Netherlands, Excerpt. Med. Int. Congr. Ser., Vol. 751, pp. 49-58.
11. Mannaerts, B., de Leeuw, R., Geelen, J., Van Ravenstein, A., Van Wezenbeek, P., Schuurs, A. and Kloosterboer, L. (1991) Comparative in vitro and in vivo studies on the biological properties of recombinant human follicle stimulating hormone. Endocrinology, 129, 2623-2630.
12. Mannaerts, B., Shoham, Z., Schoot, D., Bouchard, P., Harlin, J., Fauser, B., Jacobs, H., Rombout, F. and Coelingh Bennink, H. (1993) Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers. Fertil. Steril., 59, 108-114.
13. Mannaerts, B., Fauser, B., Lahlou, N., Harlin, J., Shoham, Z., Coelingh Bennink, H. and Bouchard, P. (1996) Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon®) in men with hypogonadotropic hypogonadism. Fertil. Steril., 65, 406-410.
14. Mason, H.D., Mannaerts, B., De Leeuw, R., Willis, S.D. and Franks, S. (1993) Effects of recombinant human follicle-stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory follicles. Hum. Reprod., 8, 1823-1827.
15. Matikainen, T., De Leeuw, R., Mannaerts, B. and Huhtaniemi, I. (1993) Circulating bioactive and immuno-reactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil. Steril., 61, 62-69.
16. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. and Coelingh Bennink, H.J.T. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
17. Out, H.J., Schnabel, P.G., Rombout, F., Geurts, T.B.P., Bosschaert, M.A.R. and Coelingh Bennink, H.J.T. (1996) A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin. Hum. Reprod., 11, 61-63.
18. Schoot, B.C., Coelingh Bennink, H.J., Mannaerts, B.M., Lamberts, S.W., Bouchard, P. and Fauser, B.C. (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J. Clin. Endocrinol. Metab., 74, 1471-1473.
19. Schoot, D.C., Harlin, J., Shoham, Z., Mannaerts, B., Lahlou, N., Bouchard, P., Coelingh Bennink, H. and Fauser, B. (1994) Human recombinant follicle-stimulating hormone and ovarian response in gonadotropin deficient women. Hum. Reprod., 9, 1237-1242.
20. Shoham, Z., Mannaerts, B., Insler, V. and Coelingh Bennink, H. (1993) Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil. Steril., 59, 738-742.
21. Steelman, S.L. and Pohley, E.M. (1953) Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin. Endocrinology, 53, 604-616.
22. Tilly, J.L., Aihara, T., Nishimori, K., Jia, X.-C., Billig, H., Kowalski, K., Perlas, E.A. and Hsueh, A.J.W. (1992) Expression of recombinant human follicle stimulating hormone receptor: species specific binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology, 131, 799-806.
23. Wide, L. and Backos, O. (1993) More basic forms of both human follicle-stimulating hormone and luteinizing hormone of serum at midcycle compared with the follicular or luteal phase. J. Clin. Endocrinol. Metab., 76, 885-889.